Drug intelligence / Profile preview

SOMEX

Development stage: Unknown
Lead developer: Novum Pharma
Modality: Drug Delivery Systems
Administration: Topical

Overview

SOMEX (also marketed as SOMEX Intima) is an over-the-counter (OTC) consumer health product developed by Novum Pharma. It is an alcohol-free emulsion specifically designed for the hygiene of the anal and vaginal regions. The product is formulated with a pH of 5.5 to match the skin's natural acidity, which helps maintain the skin's protective barrier and prevent itching or damage in sensitive intimate areas. SOMEX is categorized as a topical hygiene product rather than a pharmaceutical drug with a specific active pharmaceutical ingredient or biological target.

Brand names: SOMEXSOMEX Intima

Beyond the preview

Go deeper on SOMEX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOMEX.

Explore the full profile